Please Wait
Applying Filters...
menu
    • menu
    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-03-23

    Virtual Booth

    An Enquiry

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    An Enquiry

    Menu

    Innomustine

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 85,668Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 1Bendeka And Trenda

    02 5Bendeka and Trenda

    03 1Bendeka/Trenda

    04 3Treakisym

    05 2Treakisym/Symbenda

    06 3Treanda

    07 1Treanda And Bendeka

    08 1Treanda and Bendeka

    PharmaCompass
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    Brand Name : Treanda

    Italy
    arrow
    CPhI Milan
    Booth #10M34
    Contact Supplier Contact Supplier
    Flag Italy
    Virtual Booth Virtual Booth
    Digital Content Digital Content
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothLundbeck CDM has decades of experience in development and production services related to APIs and custom manufacturing services.

    Lundbeck

    Bendamustine Hydrochloride

    Main Therapeutic Indication : Oncology

    Currency : USD

    2014 Revenue in Millions : 64%

    2013 Revenue in Millions :

    Growth (%) :

    Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Brand Name : Bendeka and Trenda

    Bendamustine Hydrochloride

    arrow
    Health 2.0 Conference
    Not Confirmed

    Brand Name : Bendeka and Trenda

    Israel
    arrow
    Health 2.0 Conference
    Not Confirmed

    Teva

    Bendamustine Hydrochloride

    Main Therapeutic Indication : Oncology

    Currency : USD

    2019 Revenue in Millions : 496

    2018 Revenue in Millions : 642

    Growth (%) : -23

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Brand Name : Treakisym/Symbenda

    Bendamustine

    arrow
    Health 2.0 Conference
    Not Confirmed

    Brand Name : Treakisym/Symbenda

    Japan
    arrow
    Health 2.0 Conference
    Not Confirmed

    Eisai

    Bendamustine

    Main Therapeutic Indication : Oncology

    Currency : USD

    2020 Revenue in Millions : 68

    2019 Revenue in Millions : 71

    Growth (%) : -4

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    Brand Name : Bendeka and Trenda

    Bendamustine Hydrochloride

    arrow
    Health 2.0 Conference
    Not Confirmed

    Brand Name : Bendeka and Trenda

    Israel
    arrow
    Health 2.0 Conference
    Not Confirmed

    Teva

    Bendamustine Hydrochloride

    Main Therapeutic Indication : Oncology

    Currency : USD

    2020 Revenue in Millions : 415

    2019 Revenue in Millions : 496

    Growth (%) : -16

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    Brand Name : Bendeka and Trenda

    Bendamustine Hydrochloride

    arrow
    Health 2.0 Conference
    Not Confirmed

    Brand Name : Bendeka and Trenda

    Israel
    arrow
    Health 2.0 Conference
    Not Confirmed

    Teva

    Bendamustine Hydrochloride

    Main Therapeutic Indication : Oncology

    Currency : USD

    2021 Revenue in Millions : 385

    2020 Revenue in Millions : 415

    Growth (%) : -7

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    Brand Name : Treakisym/Symbenda

    Bendamustine

    arrow
    Health 2.0 Conference
    Not Confirmed

    Brand Name : Treakisym/Symbenda

    Japan
    arrow
    Health 2.0 Conference
    Not Confirmed

    Eisai

    Bendamustine

    Main Therapeutic Indication : Oncology

    Currency : USD

    2021 Revenue in Millions : 44

    2020 Revenue in Millions : 66

    Growth (%) : -28

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    Brand Name : Bendeka and Trenda

    Bendamustine Hydrochloride

    arrow
    Health 2.0 Conference
    Not Confirmed

    Brand Name : Bendeka and Trenda

    Israel
    arrow
    Health 2.0 Conference
    Not Confirmed

    Teva

    Bendamustine Hydrochloride

    Main Therapeutic Indication : Oncology

    Currency : USD

    2022 Revenue in Millions : 316

    2021 Revenue in Millions : 385

    Growth (%) : -18

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    Brand Name : Bendeka and Trenda

    Bendamustine Hydrochloride

    arrow
    Health 2.0 Conference
    Not Confirmed

    Brand Name : Bendeka and Trenda

    Israel
    arrow
    Health 2.0 Conference
    Not Confirmed

    Teva

    Bendamustine Hydrochloride

    Main Therapeutic Indication : Oncology

    Currency : USD

    2023 Revenue in Millions : 241

    2022 Revenue in Millions : 316

    Growth (%) : -24

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    09

    Brand Name : Bendeka/Trenda

    Bendamustine Hydrochloride

    arrow
    Health 2.0 Conference
    Not Confirmed

    Brand Name : Bendeka/Trenda

    Israel
    arrow
    Health 2.0 Conference
    Not Confirmed

    Teva

    Bendamustine Hydrochloride

    Main Therapeutic Indication : Oncology

    Currency : USD

    2024 Revenue in Millions : 168

    2023 Revenue in Millions : 237

    Growth (%) : -29

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    10

    Brand Name : Treanda

    Bendamustine Hydrochloride

    arrow
    Health 2.0 Conference
    Not Confirmed

    Brand Name : Treanda

    Israel
    arrow
    Health 2.0 Conference
    Not Confirmed

    Teva

    Bendamustine Hydrochloride

    Main Therapeutic Indication : Oncology

    Currency : USD

    2014 Revenue in Millions : 8.20%

    2013 Revenue in Millions :

    Growth (%) :

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.